Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M6,794Revenue $M1,117Net Margin (%)15.7Z-Score6.5
Enterprise Value $M6,317EPS $3.3Operating Margin %26.9F-Score6
P/E(ttm))42.0Cash Flow Per Share $4.9Pre-tax Margin (%)25.9Higher ROA y-yN
Price/Book5.710-y EBITDA Growth Rate %0Quick Ratio1.3Cash flow > EarningsY
Price/Sales6.15-y EBITDA Growth Rate %68.1Current Ratio1.4Lower Leverage y-yY
Price/Cash Flow10.6y-y EBITDA Growth Rate %-28.1ROA % (ttm)9.5Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)15.7Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M47.5ROI % (ttm)20.2Gross Margin Increase y-yY

Gurus Latest Trades with UTHR

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
UTHRJean-Marie Eveillard 2014-09-30 Buy 0.08%$86.44 - $136.16
($102.87)
$ 144.1140%New holding, 262080 sh.262,080
UTHRJohn Hussman 2014-09-30 Reduce-0.57%$86.44 - $136.16
($102.87)
$ 144.1140%Reduce -62.69%50,000
UTHRJoel Greenblatt 2014-09-30 Reduce-0.4%$86.44 - $136.16
($102.87)
$ 144.1140%Reduce -55.36%288,401
UTHRJoel Greenblatt 2014-06-30 Add0.37%$86.14 - $107.81
($96.29)
$ 144.1150%Add 104.14%646,066
UTHRJoel Greenblatt 2014-03-31 Add0.17%$90.67 - $113.39
($102.75)
$ 144.1140%Add 62.64%316,489
UTHRJohn Hussman 2013-12-31 Reduce-1%$80.03 - $114.51
($89.93)
$ 144.1160%Reduce -62.57%134,000
UTHRJoel Greenblatt 2013-12-31 Reduce-0.45%$80.03 - $114.51
($89.93)
$ 144.1160%Reduce -47.71%194,595
UTHRJohn Hussman 2013-09-30 Reduce-0.33%$66.1 - $79.58
($73.08)
$ 144.1197%Reduce -23.5%358,000
UTHRVanguard Health Care Fund 2013-09-30 Sold Out -0.32%$66.1 - $79.58
($73.08)
$ 144.1197%Sold Out0
UTHRDavid Dreman 2013-09-30 Sold Out -0.12%$66.1 - $79.58
($73.08)
$ 144.1197%Sold Out0
UTHRJoel Greenblatt 2013-06-30 Add0.13%$59.64 - $69.31
($64.42)
$ 144.11124%Add 15.34%341,330
UTHRDavid Dreman 2012-12-31 Buy 0.09%$44.99 - $58.91
($52.11)
$ 144.11176%New holding, 57025 sh.57,025
UTHRHOTCHKIS & WILEY 2012-12-31 Sold Out -0.09%$44.99 - $58.91
($52.11)
$ 144.11176%Sold Out0
UTHRJohn Hussman 2012-09-30 Buy 0.67%$49.73 - $58.2
($54.16)
$ 144.11166%New holding, 500000 sh.500,000
UTHRHOTCHKIS & WILEY 2012-09-30 Add0.06%$49.73 - $58.2
($54.16)
$ 144.11166%Add 270.56%266,800
UTHRJoel Greenblatt 2012-06-30 Add0.6%$41.19 - $49.51
($44.12)
$ 144.11227%Add 101.59%332,744
UTHRHOTCHKIS & WILEY 2012-06-30 Buy 0.02%$41.19 - $49.51
($44.12)
$ 144.11227%New holding, 72000 sh.72,000
UTHRRichard Perry 2012-06-30 Sold Out -0.04%$41.19 - $49.51
($44.12)
$ 144.11227%Sold Out0
UTHRJoel Greenblatt 2012-03-31 Add0.31%$45.54 - $50.99
($45.17)
$ 144.11219%Add 82.68%165,063
UTHRRichard Perry 2012-03-31 Buy 0.04%$45.54 - $50.99
($45.17)
$ 144.11219%New holding, 15300 sh.15,300
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

UTHR is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
UTHR Jean-Marie Eveillard 2014-09-30262,0800.550.08New Buy
UTHR Joel Greenblatt 2014-09-30288,4010.610.37-55.36%
UTHR John Hussman 2014-09-3050,0000.110.55-62.69%
Premium Most recent portfolio changes are included for Premium Members only!


UTHR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ROTHBLATT MARTINE AChairman & Co-CEO 2015-01-22Sell11,873$146.760.66view
ROTHBLATT MARTINE AChairman & Co-CEO 2015-01-20Sell2,592$145.061.84view
ZACCARDELLI DAVIDEVP & COO 2015-01-20Sell4,000$146.480.85view
JEFFS ROGERPresident & Co-CEO 2015-01-20Sell10,000$146.480.85view
ROTHBLATT MARTINE AChairman & Co-CEO 2015-01-15Sell9,662$137.517.43view
MAHON PAUL AEVP & General Counsel 2015-01-15Sell6,000$137.847.17view
Ferrari John MaximCFO 2015-01-15Sell22,500$137.847.17view
ROTHBLATT MARTINE AChairman & Co-CEO 2015-01-12Sell2,592$13211.92view
ROTHBLATT MARTINE AChairman & Co-CEO 2015-01-08Sell9,662$128.3115.14view
PATUSKY CHRISTOPHERDirector 2015-01-08Sell5,000$128.1315.3view

Press Releases about UTHR :

    Quarterly/Annual Reports about UTHR:

    News about UTHR:

    Articles On GuruFocus.com
    Weekly CFO Sells Highlight: United Therapeutics Corp, Williams Companies Inc, Facebook Inc. Oct 12 2014 
    Here are 5 Good Companies to Consider Investing In Right Now Feb 11 2014 
    High-Dollar Insider Sells - Zuckerberg Sells 41M Facebook Shares Dec 27 2013 
    John Hussman's Third Quarter Top 5 Nov 07 2013 
    Vanguard Health Care Fund Selling Update Oct 30 2013 
    comment on UTHR May 11 2013 
    Super-Fast Growing Mid-Cap Growth Stocks with Explosive Returns May 09 2013 
    5 Fast-Growing Small-Cap Stocks to Watch Mar 26 2013 
    comment on UTHR Mar 23 2013 
    fd Jan 12 2013 

    More From Other Websites
    Ulta Among IBD 50 Stocks Setting Up In Shaky Market Jan 16 2015
    Arena Pharmaceuticals Doses for Cardiovascular Study - Analyst Blog Jan 16 2015
    NetEase, Other Leading Stocks Break Out To New Highs Jan 15 2015
    Biotech Stock United Therapeutics Tests New Buy Point Jan 15 2015
    United Therapeutics Corporation To Present At 33rd Annual J.P. Morgan Healthcare Conference Jan 06 2015
    United Therapeutics Corporation To Present At 33rd Annual J.P. Morgan Healthcare Conference Jan 06 2015
    UPDATE: Barclays Initiates Coverage On United Therapeutics Jan 06 2015
    UPDATE: BTIG Initiates Coverage On United Therapeutics Jan 05 2015
    United Therapeutics Announces Signing Of Agreement For New Remodulin Delivery System Dec 31 2014
    UNITED THERAPEUTICS CORP Files SEC form 8-K, Regulation FD Disclosure Dec 31 2014
    United Therapeutics Announces Signing Of Agreement For New Remodulin Delivery System Dec 31 2014
    United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug... Dec 24 2014
    UNITED THERAPEUTICS CORP Files SEC form 8-K, Regulation FD Disclosure Dec 24 2014
    United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug... Dec 24 2014
    United Therapeutics Lung Drug Keeps Going And Going Dec 19 2014
    United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change Dec 17 2014
    UNITED THERAPEUTICS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in... Dec 17 2014
    United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change Dec 17 2014
    Can United Therapeutics find a remedy for recent resistance? Dec 11 2014
    Stocks Fall To Session Lows: GoPro Gives Up More Ground Dec 08 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK